Earnings calendar/RYTM
Rhythm Pharmaceuticals, Inc. (RYTM)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.73
Street estimate
Revenue target
$83.9M
Street estimate
Trailing EPS (avg 4Q)
$-0.78
Beat rate last 4: 75%
Latest EPS YoY
+2.7%
vs 2025-08-05
Latest revenue YoY
+46.9%
How results look so far
Trailing revenue (avg 4Q)
$60.0M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 4, 2026
EPS beat
EPS actual / est
$-0.73 / $-0.81
+9.6%
Revenue actual / est
$71.3M / $67.7M
+5.3%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.73 | Pending | — | $83.9M | Pending | — |
| 8/4/2026 | $-0.81 | $-0.73 | +9.6% | $67.7M | $71.3M | +5.3% |
| 5/6/2026upcoming | $-0.84 | Pending | — | $55.3M | Pending | — |
| 5/5/2026 | $-0.86 | $-0.83 | +3.5% | $55.8M | $60.1M | +7.8% |
| 2/26/2026 | $-0.79 | $-0.73 | +7.6% | $56.2M | $57.3M | +1.9% |
| 2/25/2026upcoming | $-0.79 | Pending | — | — | Pending | — |
| 11/4/2025 | $-0.72 | $-0.82 | -13.9% | $56.0M | $51.3M | -8.4% |
| 8/5/2025 | $-0.66 | $-0.75 | -13.6% | $51.3M | $48.5M | -5.5% |
| 5/7/2025 | $-0.69 | $-0.81 | -17.4% | $43.3M | $32.7M | -24.4% |
| 2/26/2025 | $-0.69 | $-0.72 | -4.3% | $38.5M | $41.8M | +8.7% |
| 11/5/2024 | $-0.80 | $-0.73 | +8.8% | $35.9M | $33.3M | -7.4% |
| 8/6/2024 | $-0.70 | $-0.55 | +21.4% | $28.8M | $29.1M | +1.0% |
| 5/7/2024 | $-2.34 | $-2.35 | -0.4% | $28.8M | $26.0M | -9.8% |
| 2/22/2024 | $-0.70 | $-0.70 | 0.0% | $25.4M | $24.2M | -4.5% |
| 11/7/2023 | $-0.76 | $-0.76 | 0.0% | $26.4M | $22.5M | -14.6% |
| 8/1/2023 | $-0.80 | $-0.82 | -2.5% | $23.0M | $19.2M | -16.3% |
| 5/2/2023 | $-0.71 | $-0.92 | -29.6% | $12.1M | $11.5M | -5.4% |
| 3/1/2023 | $-0.82 | $-0.75 | +8.5% | $7.2M | $8.8M | +21.8% |
| 11/8/2022 | $-1.01 | $-0.79 | +21.8% | $4.8M | $4.3M | -10.0% |
| 8/2/2022 | $-0.79 | $-0.89 | -12.7% | $2.6M | $9.1M | +253.4% |
| 5/3/2022 | $-0.98 | $-1.05 | -7.1% | $2.3M | $1.5M | -34.9% |
| 3/1/2022 | $-1.00 | $-0.85 | +15.0% | $1.7M | $1.8M | +6.7% |
| 11/2/2021 | $-0.84 | $-0.70 | +16.7% | $940,000 | $1.0M | +9.4% |
| 8/3/2021 | $-0.75 | $-0.70 | +6.7% | $274,000 | $274,000 | 0.0% |
| 5/3/2021 | $-0.23 | $0.90 | +492.2% | $35,000 | $35,000 | 0.0% |
| 3/1/2021 | $-0.81 | $-0.79 | +2.5% | — | Pending | — |
| 11/2/2020 | $-0.83 | $-0.77 | +7.2% | — | Pending | — |
| 8/3/2020 | $-0.83 | $-0.71 | +14.5% | — | Pending | — |
| 5/4/2020 | $-0.80 | $-0.78 | +2.5% | — | Pending | — |
| 3/2/2020 | $-0.91 | $-0.78 | +14.3% | — | Pending | — |
| 11/1/2019 | $-1.05 | $-1.04 | +1.0% | — | Pending | — |
| 7/29/2019 | $-0.81 | $-1.24 | -53.1% | — | Pending | — |
| 5/3/2019 | $-0.69 | $-0.84 | -21.7% | — | Pending | — |
| 3/8/2019 | $-0.56 | $-0.74 | -32.1% | — | Pending | — |
| 11/9/2018 | $-0.41 | $-0.52 | -26.8% | — | Pending | — |
| 8/8/2018 | $-0.40 | $-0.52 | -30.0% | — | Pending | — |
| 5/14/2018 | $-0.45 | $-0.60 | -33.3% | — | Pending | — |
| 3/12/2018 | $-0.55 | $-0.41 | +25.5% | — | Pending | — |
| 11/14/2017 | $-0.40 | $-1.51 | -277.5% | — | Pending | — |
| 10/5/2017 | — | $-0.26 | — | — | Pending | — |
| 3/31/2017 | — | $-0.38 | — | — | Pending | — |
| 12/31/2016 | — | $-0.50 | — | — | Pending | — |
| 9/30/2016 | — | $-0.38 | — | — | Pending | — |
| 6/30/2016 | — | $-0.64 | — | — | Pending | — |
| 3/31/2016 | — | $-0.61 | — | — | Pending | — |
| 12/31/2015 | — | $-0.66 | — | — | Pending | — |
| 9/30/2015 | — | $-0.34 | — | — | Pending | — |
| 6/30/2015 | — | $-0.09 | — | — | Pending | — |
| 3/31/2015 | — | $-0.09 | — | — | Pending | — |
| 12/31/2014 | — | $-0.07 | — | — | Pending | — |
| 9/30/2014 | — | $-0.02 | — | — | Pending | — |
| 6/30/2014 | — | $-0.27 | — | — | Pending | — |
| 3/31/2014 | — | $-0.27 | — | — | Pending | — |
Need RYTM data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.